ID28802A - Turunan indol - Google Patents

Turunan indol

Info

Publication number
ID28802A
ID28802A IDW00200101132A ID20011132A ID28802A ID 28802 A ID28802 A ID 28802A ID W00200101132 A IDW00200101132 A ID W00200101132A ID 20011132 A ID20011132 A ID 20011132A ID 28802 A ID28802 A ID 28802A
Authority
ID
Indonesia
Prior art keywords
indol
indol down
Prior art date
Application number
IDW00200101132A
Other languages
English (en)
Indonesian (id)
Inventor
Christopher Ian Daliman
Ronald James Ogilvie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ID28802A publication Critical patent/ID28802A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Lasers (AREA)
  • Electroluminescent Light Sources (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW00200101132A 1998-11-27 1999-11-01 Turunan indol ID28802A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825988.0A GB9825988D0 (en) 1998-11-27 1998-11-27 Indole derivatives

Publications (1)

Publication Number Publication Date
ID28802A true ID28802A (id) 2001-07-05

Family

ID=10843140

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101132A ID28802A (id) 1998-11-27 1999-11-01 Turunan indol

Country Status (53)

Country Link
US (2) US20020013358A1 (fr)
EP (1) EP1135381B1 (fr)
JP (1) JP3777094B2 (fr)
KR (1) KR100413739B1 (fr)
CN (1) CN1131860C (fr)
AP (1) AP2001002149A0 (fr)
AR (1) AR024232A1 (fr)
AT (1) ATE273300T1 (fr)
AU (1) AU754731B2 (fr)
BG (1) BG64706B1 (fr)
BR (1) BR9915692A (fr)
CA (1) CA2352392C (fr)
CO (1) CO5150178A1 (fr)
CR (1) CR6325A (fr)
CU (1) CU23269A3 (fr)
CZ (1) CZ295472B6 (fr)
DE (1) DE69919388T2 (fr)
DK (1) DK1135381T3 (fr)
DZ (1) DZ2948A1 (fr)
EA (1) EA003551B1 (fr)
EE (1) EE04914B1 (fr)
ES (1) ES2224701T3 (fr)
GB (1) GB9825988D0 (fr)
GC (1) GC0000113A (fr)
GE (1) GEP20043183B (fr)
GT (1) GT199900202A (fr)
HK (1) HK1042898B (fr)
HN (1) HN1999000196A (fr)
HR (1) HRP20010398B1 (fr)
HU (1) HUP0105308A3 (fr)
ID (1) ID28802A (fr)
IL (1) IL141663A (fr)
IS (1) IS2238B (fr)
MA (1) MA26708A1 (fr)
MY (1) MY124078A (fr)
NO (1) NO320798B1 (fr)
NZ (1) NZ510055A (fr)
OA (1) OA11671A (fr)
PA (1) PA8485701A1 (fr)
PE (1) PE20001299A1 (fr)
PL (1) PL194503B1 (fr)
PT (1) PT1135381E (fr)
RS (1) RS50002B (fr)
SI (1) SI1135381T1 (fr)
SK (1) SK285774B6 (fr)
SV (1) SV1999000204A (fr)
TN (1) TNSN99221A1 (fr)
TR (1) TR200101493T2 (fr)
TW (1) TWI246512B (fr)
UA (1) UA68402C2 (fr)
UY (2) UY25823A1 (fr)
WO (1) WO2000032589A1 (fr)
ZA (1) ZA200102681B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
BRPI0409127A (pt) 2003-04-11 2006-03-28 Pfizer combinação farmacêutica compreendendo eletriptano e bicarbonato de sódio
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
US6927296B2 (en) 2003-07-23 2005-08-09 Pfizer Inc. Process
EP2093225A1 (fr) 2007-05-01 2009-08-26 Plus Chemicals B.V. Procédé de préparation de la forme ß de l'hydrobromide d'élétriptan crystallin
WO2008150500A1 (fr) * 2007-05-29 2008-12-11 Plus Chemicals, S.A. Procédé pour préparer du 5-bromo-3-[(r)-1-méthyl-pyrrolidin-2-yl-méthyl]-1h-indole
EP2225224A2 (fr) * 2007-12-17 2010-09-08 Actavis Group PTC EHF Sel semioxalate innovant de l'élétriptan
WO2010097703A1 (fr) * 2009-02-25 2010-09-02 Actavis Group Ptc Ehf Elétriptan de pureté élevée ou un de ses sels pharmaceutiquement acceptables essentiellement exempt d'impuretés n-oxydes d'élétriptan
WO2010116386A2 (fr) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Nouveau polymorphe de bromhydrate d'életriptan et son procédé de fabrication
US8754239B2 (en) 2010-01-19 2014-06-17 Sms Pharmaceuticals Limited Process for preparing eletriptan hydrobromide having α-form
WO2014063752A1 (fr) 2012-10-26 2014-05-01 Synthon Bv Procédé de production de la forme cristalline alpha du bromhydrure d'élétriptan
CN103893112A (zh) * 2012-12-31 2014-07-02 重庆圣华曦药业股份有限公司 氢溴酸依来曲普坦注射液
CN107954947A (zh) * 2016-10-14 2018-04-24 北京莱瑞森医药科技有限公司 沃替西汀氢溴酸盐晶型c及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5474784A (en) * 1990-03-02 1995-12-12 British Technology Group Limited Dispensing device
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
AU651637B2 (en) 1990-10-15 1994-07-28 Pfizer Inc. Indole derivatives
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
TW448172B (en) * 1996-03-08 2001-08-01 Pharmacia & Upjohn Co Llc Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
WO1999001135A1 (fr) 1997-07-03 1999-01-14 Pfizer Limited Compositions pharmaceutiques contenant hemisulfate d'eletriptane et cafeine

Also Published As

Publication number Publication date
IL141663A (en) 2004-05-12
JP3777094B2 (ja) 2006-05-24
EE200100285A (et) 2002-08-15
SI1135381T1 (en) 2004-10-31
GB9825988D0 (en) 1999-01-20
MA26708A1 (fr) 2004-12-20
UY25823A1 (es) 2001-08-27
DE69919388T2 (de) 2005-09-29
IS2238B (is) 2007-05-15
EP1135381A1 (fr) 2001-09-26
EA003551B1 (ru) 2003-06-26
PE20001299A1 (es) 2000-12-01
SV1999000204A (es) 2000-10-16
DE69919388D1 (de) 2004-09-16
GEP20043183B (en) 2004-02-25
EA200100297A1 (ru) 2001-08-27
PL347928A1 (en) 2002-04-22
PL194503B1 (pl) 2007-06-29
HRP20010398B1 (en) 2004-12-31
BG64706B1 (bg) 2005-12-30
US20050131237A1 (en) 2005-06-16
ES2224701T3 (es) 2005-03-01
CZ20011839A3 (cs) 2001-10-17
HRP20010398A2 (en) 2002-06-30
CA2352392C (fr) 2006-01-24
PA8485701A1 (es) 2000-09-29
TWI246512B (en) 2006-01-01
US20020013358A1 (en) 2002-01-31
KR100413739B1 (ko) 2004-01-03
WO2000032589A1 (fr) 2000-06-08
SK285774B6 (sk) 2007-08-02
DK1135381T3 (da) 2004-11-15
ATE273300T1 (de) 2004-08-15
SK6992001A3 (en) 2002-01-07
OA11671A (en) 2005-01-12
UA68402C2 (en) 2004-08-16
YU18801A (sh) 2003-07-07
MY124078A (en) 2006-06-30
TR200101493T2 (tr) 2002-02-21
NO20012584L (no) 2001-07-27
NZ510055A (en) 2004-11-26
BR9915692A (pt) 2001-08-14
IS5868A (is) 2001-02-27
PT1135381E (pt) 2004-10-29
HUP0105308A3 (en) 2003-01-28
CZ295472B6 (cs) 2005-08-17
AU754731B2 (en) 2002-11-21
US7238723B2 (en) 2007-07-03
NO20012584D0 (no) 2001-05-25
UY25825A1 (es) 2000-08-21
CR6325A (fr) 2008-07-02
CN1328554A (zh) 2001-12-26
DZ2948A1 (fr) 2004-03-15
TNSN99221A1 (fr) 2005-11-10
AP2001002149A0 (en) 2001-06-30
CA2352392A1 (fr) 2000-06-08
IL141663A0 (en) 2002-03-10
ZA200102681B (en) 2002-07-02
CN1131860C (zh) 2003-12-24
HN1999000196A (es) 2005-11-26
RS50002B (sr) 2008-09-29
EP1135381B1 (fr) 2004-08-11
GC0000113A (en) 2005-06-29
KR20010080594A (ko) 2001-08-22
NO320798B1 (no) 2006-01-30
EE04914B1 (et) 2007-10-15
HK1042898B (zh) 2004-10-08
CU23269A3 (es) 2008-04-09
AR024232A1 (es) 2002-09-25
JP2002531449A (ja) 2002-09-24
HUP0105308A2 (hu) 2002-05-29
BG105539A (en) 2001-12-29
CO5150178A1 (es) 2002-04-29
AU6225399A (en) 2000-06-19
GT199900202A (es) 2001-05-19
HK1042898A1 (en) 2002-08-30

Similar Documents

Publication Publication Date Title
ID29066A (id) Turunan fenilglisina
ID27423A (id) Turunan kuinolin
ID23234A (id) Turunan-turunan benzosulfona
DE50014679D1 (de) Substituierte indol-mannichbasen
DE69904565T2 (de) Hubventilsteuerungseinrichtung
DE59901560D1 (de) Retrograder tibianagel
ID27484A (id) Turunan adenosina
DE59902874D1 (de) Buchsenkontakt
ID27547A (id) Turunan kuinolin
DE59907306D1 (de) Fadenchangierung
DE59906931D1 (de) Exzenterzahnradgetriebe
ID24221A (id) Tempat patrum
DE59903966D1 (de) Exzenterzahnradgetriebe
DE59908968D1 (de) Benzoylpyridazine
ID28802A (id) Turunan indol
DE59908769D1 (de) N-arylsulfonyl-aminosäure-omega-amide
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
ID28624A (id) Turunan 2-fenilpiran-4-on
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE69809804T2 (de) Notlaufgeländereifen
DE59908057D1 (de) Underdruckhandhabungseinrichung
DE59807217D1 (de) Nadellager
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
ID28356A (id) Turunam tiazola
DE19842103B4 (de) Stanznietzuführung